Blood PressureNCT06719518
Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device
An observational study of Blood Pressure, run by The University of Texas Health Science Center, Houston at 1 site in United States.
Trial summary
The purpose of this study is to calibrate the ViTrack™ arterial pressure waveform against intra-arterial pressure (IAP) in dynamic clinical settings and to assess the optimized ViTrack™ design to measure and continuously track blood pressure over a wide, clinically-relevant pressure range. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Blood Pressure
- What is being tested?
- ViTrack device
- Type of treatment
- Medical device
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- 17 Dec 2025to 31 Jul 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: subjects scheduled to undergo noncardiac surgery with likely invasive arterial pressure monitoring will be included will be included
Who may be able to join
- scheduled to undergo noncardiac surgery with general or spinal anesthesia
- clinical indication for invasive intra-arterial pressure monitoring
- palpable pulse
Who cannot join
- difference of greater than 10 mmHg in the left versus right arm oscillometric systolic blood pressure
- Upper extremity arteriovenous hemodialysis shunt
- Upper extremity amputation
- Planned surgical position/draping that precludes access to the wrist
- Wrist distortion or pain from arthritis
- Prior trauma or surgery at the radial artery monitoring site
- Unable to provide informed consent
- Clinical contraindication as determined by the clinical team or study investigators
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
The University of Texas Health Science Center at Houston
Houston, Texas, 77030
Mehmet Turan, MD, (713) 500-6251, Mehmet.A.Turan@uth.tmc.edu
Mohammad Khudirat, (713) 500-6200, Mohammad.Khudirat@uth.tmc.edu
About this study
The purpose of this study is to calibrate the ViTrack™ arterial pressure waveform against intra-arterial pressure (IAP) in dynamic clinical settings and to assess the optimized ViTrack™ design to measure and continuously track blood pressure over a wide, clinically-relevant pressure range.
- Conditions
- Blood Pressure
- Being tested
- ViTrack device
- Keywords
- ViTrack, blood pressure monitoring
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ViTrack deviceDevice
In the operating room the ViTrack™ device will be applied the wrist. Monitoring will start in the operating room and will continue throughout the surgery. The device can be worn on either wrist. It will be connected to a power unit that will capture blood pressure data and stream the data to a secure laptop
| Study group | Role | What they receive |
|---|---|---|
| ViTrack device | Not described Receives: Device: ViTrack device |
What is being measured
The primary outcome is the main question the study is designed to answer.
Comparison of Diastolic Blood Pressure
255 time points compared across continuous blood pressure (mmHg)
Measured: From start of surgery up to 24 hours after surgery
Comparison of Systolic Blood Pressure
255 time points compared across continuous blood pressure (mmHg)
Measured: From start of surgery up to 24 hours after surgery
Secondary outcomes (1)
Number of participants who show signs of Skin Irritation
Measured: From start of surgery up to 72 hours after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Dec 2024
- Study start17 Dec 2025
- Primary completion31 Jul 2026 (estimated)
- Study completion31 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blood PressureStudies of the same condition, open and under way.
- More trials run by The University of Texas Health Science Center, HoustonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mehmet Turan, The University of Texas Health Science Center, Houston
- Investigators
- Mehmet Turan, MD, Principal investigator, The University of Texas Health Science Center, Houston
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06719518
- Sponsor's protocol ID
- HSC-MS-24-0970
- Status last verified
- Feb 2026
- First submitted
- 2 Dec 2024
- Last updated
- 27 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device
- ClinicalTrials.gov ID
- NCT06719518
- Acronym / sponsor ID
- HSC-MS-24-0970
- Conditions
- Blood Pressure
- Keywords
- ViTrack, blood pressure monitoring
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- The University of Texas Health Science Center, HoustonUniversity, hospital or other
- Study start
- 17 Dec 2025 (actual)
- Primary completion
- 31 Jul 2026 (estimated)
- Study completion
- 31 Jul 2026 (estimated)
- First posted
- 5 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to calibrate the ViTrack™ arterial pressure waveform against intra-arterial pressure (IAP) in dynamic clinical settings and to assess the optimized ViTrack™ design to measure and continuously track blood pressure over a wide, clinically-relevant pressure range.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| ViTrack device | – | Device: ViTrack device |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- subjects scheduled to undergo noncardiac surgery with likely invasive arterial pressure monitoring will be included will be included
Key inclusion criteria (3 listed)
- scheduled to undergo noncardiac surgery with general or spinal anesthesia
- clinical indication for invasive intra-arterial pressure monitoring
- palpable pulse
Key exclusion criteria (8 listed)
- difference of greater than 10 mmHg in the left versus right arm oscillometric systolic blood pressure
- Upper extremity arteriovenous hemodialysis shunt
- Upper extremity amputation
- Planned surgical position/draping that precludes access to the wrist
- Wrist distortion or pain from arthritis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ViTrack deviceIn the operating room the ViTrack™ device will be applied the wrist. Monitoring will start in the operating room and will continue throughout the surgery. The device can be worn on either wrist. It will be connected to a power unit that will capture blood pressure data and stream the data to a secure laptop | Device | ViTrack device |
Primary outcome
Comparison of Diastolic Blood Pressure
Time frame: From start of surgery up to 24 hours after surgery
255 time points compared across continuous blood pressure (mmHg)
Comparison of Systolic Blood Pressure
Time frame: From start of surgery up to 24 hours after surgery
255 time points compared across continuous blood pressure (mmHg)
1 secondary outcome
Number of participants who show signs of Skin Irritation
Time frame: From start of surgery up to 72 hours after surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Blood Pressure
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingPhase 4
Hematological Safety of Dipyrone Versus Paracetamol After Dental Extractions
Hematologic Test, Agranulocytosis
Not yet recruiting
Acute Effects of Mat Pilates on Blood Pressure Response to Mental Stress in Higher Education Teachers
Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mehmet Turan, MD principal investigator
The University of Texas Health Science Center, Houston
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Blood Pressure, run by The University of Texas Health Science Center, Houston at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mehmet Turan, MD ((713) 500-6251, Mehmet.A.Turan@uth.tmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Comparison of Diastolic Blood Pressure (time frame: From start of surgery up to 24 hours after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Feb 2026.